Study of the effects of febuxostat in patients with diabetic nephropathy.
Phase of Trial: Phase II
Latest Information Update: 31 Mar 2015
At a glance
- Drugs Febuxostat (Primary)
- Indications Diabetic nephropathies; Hyperuricaemia
- Focus Pharmacodynamics
- 30 Mar 2015 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 31 Oct 2014 New trial record